2018
DOI: 10.2147/ndt.s168469
|View full text |Cite
|
Sign up to set email alerts
|

Interstitial deletion within 7q31.1q31.3 in a woman with mild intellectual disability and schizophrenia

Abstract: We report the case of a Japanese woman with an interstitial deletion within the 7q31.1q31.3 region, she presented with mild intellectual disability since infancy, and later developed characteristic psychiatric manifestations, including abnormal behavior, delusions, and hallucinations. She was diagnosed with paranoid schizophrenia (F20.0, International Statistical Classification of Diseases and Related Health Problems 10th Revision). Array comparative genomic hybridization examination revealed the deletion invo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 32 publications
0
6
0
Order By: Relevance
“…A 1.11 Mb deletion in 16p13.2. This partially encompasses the GRIN2A and USP7 genes associated with neurodevelopmental disorders, including autistic features [ 34 , 43 ].…”
Section: Resultsmentioning
confidence: 99%
“…A 1.11 Mb deletion in 16p13.2. This partially encompasses the GRIN2A and USP7 genes associated with neurodevelopmental disorders, including autistic features [ 34 , 43 ].…”
Section: Resultsmentioning
confidence: 99%
“…Thus, activators or inhibitors for DOCK1, 2, and 4 may be detected by a similar screening method. These proteins may be involved in the pathogenesis of cancer, AD, autism, schizophrenia, and so on [ 27 30 ]. Thus, activators or inhibitors of DOCK1–4 may be useful for various diseases other than CNS degeneration, such as COVID-19-associated diseases [ 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…Mutations or reduced expression of DOCK4 is related to malignancies in breast (Kobayashi et al, 2014), lung (Yu et al, 2015), brain (Debruyne et al, 2018) and blood tissues (Sundaravel et al, 2019) as well as tumor metastasis (Hiramoto et al, 2006). Dysfunctional DOCK4 is also involved in several neuropsychiatric disorders, including autism, dyslexia, mild intellectual disability (Huang M. et al, 2019), schizophrenia (Akahoshi and Yamamoto, 2018) and hearing impairment (Uehara et al, 2015). In addition, DOCK4 boosts atherosclerosis via internalization of SR-B1 and transport of LDL (Huang L. et al, 2019).…”
Section: Discussionmentioning
confidence: 99%